High-dose radioimmunotherapy/chemotherapy and autologous stem cell transplantation (ASCT) for poor risk and relapsed CD20+non-Hodgkin's lymphoma (NHL): Early feasibility report.

被引：0
|
作者：
Raubitschek, A
Nademanee, A
Molina, A
Rodriguez, R
White, C
Forman, S
机构：
[1] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[2] Idec Pharmaceut Corp, San Diego, CA USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5372
引用
收藏
页码：374B / 375B
页数：2
相关论文
共 50 条
  • [1] High-dose sequential chemotherapy (HDSC) in support of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL)
    Oyan, B
    Koc, Y
    Ozdemir, E
    Kansu, E
    BLOOD, 2004, 104 (11) : 393B - 393B
  • [2] High-dose chemotherapy and hemopoietic stem cell transplantation (ASCT) in poor-prognosis non Hodgkin's lymphoma
    Patti, C
    Cavallaro, A
    Tringali, S
    Indovina, A
    Santoro, A
    Costa, A
    Mistretta, A
    Cascio, L
    Pagano, M
    Rizzo, A
    Stella, M
    Scimè, R
    BONE MARROW TRANSPLANTATION, 2002, 29 : S86 - S86
  • [3] High-dose chemotherapy and autologous stem cell transplantation for Korean patients with relapsed or refractory Hodgkin's lymphoma
    Park, K.
    Yoon, D.
    Kim, S.
    Huh, J.
    Park, C.
    Lee, S.
    Park, S.
    Ahn, Y.
    Jo, J.
    Suh, C.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S445 - S445
  • [4] Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome
    Nieto, Yago
    Popat, Uday
    Anderlini, Paolo
    Valdez, Ben
    Andersson, Borje
    Liu, Ping
    Hosing, Chitra
    Shpall, Elizabeth J.
    Alousi, Amin
    Kebriaei, Partow
    Qazilbash, Muzaffar
    Parmar, Simrit
    Bashir, Qaiser
    Shah, Nina
    Khouri, Issa
    Rondon, Gabriela
    Champlin, Richard
    Jones, Roy B.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (03) : 410 - 417
  • [5] High-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma
    Provencio, Mariano
    Fayad, Luis E.
    MEDICINA CLINICA, 2008, 130 (02): : 60 - 65
  • [6] High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma
    Rancea, Michaela
    Monsef, Ina
    von Tresckow, Bastian
    Engert, Andreas
    Skoetz, Nicole
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (06):
  • [7] High-dose chemotherapy and autologous stem cell transplantation for relapsed Hodgkin's disease.
    Fetscher, S
    Waller, CF
    Technau, K
    Wild, Y
    Lange, W
    BONE MARROW TRANSPLANTATION, 1999, 23 : S104 - S104
  • [8] High-dose therapy and stem cell transplantation (BMT) for relapsed or refractory non-Hodgkin's lymphoma (NHL).
    Shahidi, H
    Gregory, SA
    GuptaBurt, S
    Adler, SS
    Venugopal, P
    Meyer, P
    Korenblit, AD
    Recine, D
    Manson, S
    Kaizer, H
    BLOOD, 1997, 90 (10) : 1023 - 1023
  • [9] High-dose Chemotherapy (HDC) with rituximab and autologous stem cell support in patients with poor prognosis non-Hodgkin's lymphoma (NHL)
    Ptushkin, V
    Mheidze, D
    Larionova, V
    Zukov, N
    Andreeva, L
    Osmanov, E
    Chimishkyan, K
    BONE MARROW TRANSPLANTATION, 2002, 29 : S95 - S95
  • [10] High-Dose Chemotherapy (HDC) and Autologous Stem Cell Transplantation (ASCT) in patients with primary refractory aggressive Non-Hodgkin's lymphoma
    Rodriguez, J
    Caballero, MD
    Solano, C
    Lahuerta, JJ
    Arranz, R
    Sureda, A
    Zuazu, J
    Marin, J
    García-Laraña, J
    López-Guillermo, A
    SanMiguel, J
    Conde, E
    BONE MARROW TRANSPLANTATION, 2001, 27 : S260 - S261
12345